Refine by
Drug Manufacturer Articles & Analysis
34 articles found
As seasonal allergies affect millions globally, the demand for advanced, reliable treatments is growing rapidly. Behind the scenes of this progress lies a powerful class of materials: fluoropolymers. While often associated with aerospace, semiconductor, and chemical industries, fluoropolymers also play a vital—yet underappreciated—role in pharmaceutical manufacturing, particularly in ...
Whether it is medical research or drug manufacturing, tablet press is a vital link. Let's see how to choose the one that suits you best.Grand pack.The field of drug delivery is constantly evolving, driven by the core goal of improving therapeutic outcomes—enhancing efficacy, reducing toxicity, boosting patient compliance, and even enabling ...
Introduction The pharmaceutical industry faces stringent regulatory requirements to ensure the safety, efficacy, and quality of drug products. Among these, Current Good Manufacturing Practice (CGMP) guidelines set by agencies such as the U.S. Food and Drug Administration (FDA) play a pivotal role. Pharmaceutical CGMP ...
We devote to accelerate clients' research in the development and manufacture of therapeutic drugs, vaccines, and diagnostics. Plants provide an inexpensive and simple system for the production of valuable recombinant proteins on large scale. ...
Successful AAV formulation demands understanding factors such as administration routes and organ-specific distribution, stability, vector aggregation, manufacturing-related impurities, and vector-host interactions. Enhancing cGMP Capacity: A Prerequisite for Efficient Therapies To accompany this technical transformation, expansion in cGMP capacity is a necessity. cGMP represents ...
Ordinary nanogels will swell when absorbing water, and their drug administration and subsequent release behavior will be single. Environmentally responsive nanogels will swell or dissolve when exposed to different environments, and their administration and subsequent release behavior will be more intelligent. ...
In response to this rapid growth, manufacturers have developed innovative ways to produce sterile packaging. ...
Upon application to the skin, the microneedles dissolve, releasing the drug payload in response to the skin's temperature. This technology enables precise control over drug release kinetics, making it suitable for various therapeutic applications. ...
This new approach to treatment incorporates patient perspectives into drug development. A key benefit is the keener focus on convenience and safe drug administration. ...
For a generic Pharma Company partnering with a CMO has several benefits, some of which are as follows: Cost Savings One of the primary benefits of partnering with a CMO is cost savings. Manufacturing a large-scale drug for a pharmaceutical company is time-consuming and costly. By partnering with a CMO, generic pharmaceutical companies can save on ...
To address this challenge, generic companies often outsource their drug development to Contract Development and Manufacturing Organizations (CDMOs), which offer end-to-end services from research to commercialization. ...
Metformin is a classic first-line hypoglycemic agent for patients with type 2 diabetes, and is an essential drug in combination regimenes. However, as the evidence is updated, the idea of drug selection for first-line treatment is changing. ...
COVID -19 Vaccine Overview The development of a COVID-19 vaccine by drug manufacturers has been welcomed across the globe. A key concern, however, is the safe distribution of the vaccines worldwide. ...
This end-to-end solution includes customisation of the appropriate device platform to meet the specific user requirements, component manufacture, filling of the primary drug container, and assembly and integration to produce the final device. ...
Mainstream Carbohydrates in the Market Since carbohydrates boast broad applications in drug and vaccine development, many manufacturers are contributing to the establishment of a complete supply chain. ...
Insilico Medicine announced the nomination of a novel preclinical therapeutic candidate for treating COVID-19, designed using the generative chemistry AI platform Chemistry42. The new drug candidate is a 3CL protease inhibitor unique from existing drugs in its class because it can be rapidly produced. ...
CEO and president Mike Hooven said the funding: “will help enFuse continue to redefine intravenous drug delivery by meaningfully scaling our development and commercialisation efforts”. ...
Pharmaceutical excipients are substances formulated together with active pharmaceutical ingredients (APIs) of the drug, and excipients account for most of the drug composition. Excipients are designed to interact with and enhance the properties of APIs. ...
This is to say that relatively more drugs will enter the lymphatic circulation and at the same time avoid the first pass effect of the drug in the liver. ...
This is to say that relatively more drugs will enter the lymphatic circulation and at the same time avoid the first pass effect of the drug in the liver. ...